If you scan the landscape of colorectal cancer screening tests in the US, you will find companies positioning their blood-based screening tests on various perches – some waiting for imminent launches,
Biopharmas large and small will try to make headway into a variety of markets and solidify or expand their foothold in existing markets at this year’s Digestive Disease Week, to be held in Chicago 6-9